贝伐珠单抗阻断血管内皮生长因子减轻兔实验性蛛网膜下腔出血后血管内皮生长因子诱导的血管痉挛
研究将32只成年雄性新西兰白兔随机分为对照组、蛛网膜下腔出血组、蛛网膜下腔出血加溶剂组和蛛网膜下腔出血加贝伐珠单抗组,每组8只。贝伐珠单抗按5 mg/kg腹腔注射,于枕大池注血后5分钟给药,每日一次持续72小时。结果显示贝伐珠单抗组基底动脉横截面积较蛛网膜下腔出血组和溶剂组显著增大,血管壁厚度显著减小,海马变性评分与对照组相似且显著低于蛛网膜下腔出血组和溶剂组。
要点
- 贝伐珠单抗5 mg/kg腹腔注射可减轻兔蛛网膜下腔出血后基底动脉血管痉挛。
- 贝伐珠单抗组基底动脉横截面积显著大于蛛网膜下腔出血组和溶剂组。
- 贝伐珠单抗组海马变性评分与对照组相似且显著低于蛛网膜下腔出血组和溶剂组。
核心结论
- 细胞增殖及随后的血管壁增厚是导致脑缺血延迟和神经认知功能恶化的原因。
- 腹腔注射贝伐珠单抗可减轻兔蛛网膜下腔出血后的脑血管痉挛,预防迟发性脑缺血并改善神经认知功能。
研究设计与样本
- 研究将32只成年雄性新西兰白兔随机分为4组,每组8只:组1为对照组,组2为蛛网膜下腔出血组,组3为蛛网膜下腔出血加溶剂组,组4为蛛网膜下腔出血加贝伐珠单抗组。
- 贝伐珠单抗按5 mg/kg腹腔注射,于枕大池注血后5分钟给药,每日一次持续72小时,同剂量。
- 动物于蛛网膜下腔出血后72小时处死,评估基底动脉横截面积、动脉壁厚度和海马变性评分。
主要发现
- 血管内皮生长因子与基底动脉狭窄相关。
- 贝伐珠单抗组基底动脉横截面积较蛛网膜下腔出血组和溶剂组显著增大。
- 贝伐珠单抗组基底动脉壁厚度较蛛网膜下腔出血组和溶剂组显著减小。
- 贝伐珠单抗组与对照组海马变性评分相似,且均显著低于蛛网膜下腔出血组和溶剂组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Vasospasm after subarachnoid hemorrhage (SAH) plays a vital role in the development of delayed cerebral ischemia. Anti- vascular endothelial growth factor (VEGF) antibodies, like bevacizumab (BEV), may attenuate VEGF-stimulated angiogenesis, reduced vascular cell proliferation, and improve vasospasm after SAH. METHODS: Thirty-two adult male New Zealand white rabbits were randomly divided into 4 groups of 8 rabbits in each group: group 1 (control); group 2 (SAH); group 3 (SAH + vehicle); and group 4 (SAH + BEV). BEV (5 mg/kg, intraperitoneally) was administered 5 minutes after the intracisternal blood injection and continued for 72 hours once per day in the same dose for group 4. Animals were sacrificed 72 hours after SAH. Basilar artery cross-sectional areas, arterial wall thicknesses, and hippocampal degeneration scores were evaluated in all groups. RESULTS: VEGF is associated with the narrowing of the basilar artery. Treatment with BEV statistically significantly increased the cross-sectional area of the basilar artery when compared with the SAH and the vehicle groups. Basilar artery wall thicknesses in the BEV group was statistically significant smaller than in the SAH and vehicle groups. The hippocampal degeneration scores for the BEV and control groups were similar and significantly lower than those for the SAH and vehicle groups. CONCLUSIONS: Cellular proliferation and subsequent vessel wall thickening is a reason to delay cerebral ischemia and deterioration of the neurocognitive function. Intraperitoneal administration of BEV was found to attenuate cerebral vasospasm and prevent delayed cerebral ischemia and improve neurocognitive function after SAH in rabbits.
引用
- Akturk UD, Tuncer C, Bozkurt H, et al. Blocking VEGF by Bevacizumab Attenuates VEGF-Induced Vasospasm After Experimental Subarachnoid Hemorrhage in Rabbits. World Neurosurg. 2020. PMID: 32251821. doi:10.1016/j.wneu.2020.03.151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。